{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:11:47Z","timestamp":1707523907747},"reference-count":0,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,19]]},"DOI":"10.7759\/cureus.2506","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T13:26:39Z","timestamp":1524144399000},"source":"Crossref","is-referenced-by-count":0,"title":["Abatacept as a Therapeutic Option for Rheumatoid Vasculitis"],"prefix":"10.7759","author":[{"given":"Layth","family":"Al Attar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Shaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/11625-abatacept-as-a-therapeutic-option-for-rheumatoid-vasculitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:14:23Z","timestamp":1707506063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/11625-abatacept-as-a-therapeutic-option-for-rheumatoid-vasculitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7759\/cureus.2506","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,19]]}}}